Effect of the phosphate binder sucroferric oxyhydroxide in dialysis patients on endogenous calciprotein particles, inflammation, and vascular cells
Author(s) -
Ursula Thiem,
Tim D. Hewitson,
Nigel D. Toussaint,
S. Holt,
Maria Haller,
Andreas Pasch,
Daniel Cejka,
Edward R. Smith
Publication year - 2022
Publication title -
nephrology dialysis transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.654
H-Index - 168
eISSN - 1460-2385
pISSN - 0931-0509
DOI - 10.1093/ndt/gfac271
Subject(s) - medicine , inflammation , endogeny , hemodialysis , dialysis , phosphate , phosphate binder , kidney disease , hyperphosphatemia , biochemistry , chemistry
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom